Cargando…

A reproducible rabbit model of acetaminophen induced acute hepatic failure (AHF) and multi-organ failure (MOF)

Detalles Bibliográficos
Autores principales:	Rahman, TM, Selden, C, Hodgson, HJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301885/ http://dx.doi.org/10.1186/cc557

Ejemplares similares

Inhibition of inducible nitric oxide synthase (iNOS) reduces multi-organ failure (MOF) in the thioacetamide (TAA) rat model
por: Rahman, TM, et al.
Publicado: (2000)

Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure
por: Rahman, TM, et al.
Publicado: (2001)

Low dose pentoxifylline (PTX) reduces mortality in an animal model of acute hepatic and multi-organ failure
por: Rahman, TM, et al.
Publicado: (2001)

Multi-organ-failure (MOF) with and without sepsis: differences in incidence and pattern of detected arrhythmias
por: Prondzinsky, R, et al.
Publicado: (1997)

Circulating markers of endothelial activation in acetaminophen induced acute liver failure
por: Bernal, W, et al.
Publicado: (1998)

The encephalopathy of acetaminophen induced acute liver failure is associated with cerebral endothelial activation
por: Bernal, W, et al.
Publicado: (1998)

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Status of AHF
por: Swain, G
Publicado: (1988)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF
por: Kagiyama, Nobuyuki, et al.
Publicado: (2018)

Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF Registry
por: Oh, Gyu Chul, et al.
Publicado: (2020)

Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)
por: Lee, Sang Eun, et al.
Publicado: (2017)

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
por: Liu, Licette C. Y., et al.
Publicado: (2016)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Some news on AHF
por: Schaffer, G
Publicado: (1989)

Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018)

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
por: Lee, Nuri, et al.
Publicado: (2022)

Sequential organ failure assessment in neurocritical care
por: Zygun, D, et al.
Publicado: (2003)

AHFS Drug information 2003 /
Publicado: (2003)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2017)

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
por: Biegus, Jan, et al.
Publicado: (2019)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
por: Su, Yang, et al.
Publicado: (2020)

Effectiveness of Yiqi Fumai lyophilized injection for acute heart failure: Rationale and design of the AUGUST-AHF cohort study
por: Zhang, Xuecheng, et al.
Publicado: (2023)

Characteristics of patients with sepsis and multiple organ failure in the UK
por: Shaikh, L, et al.
Publicado: (1999)

Incidence of organ failure in patients with severe acute pancreatitis
por: Lapauw, S, et al.
Publicado: (2003)

CVVH versus IHD in patients with multiple organ failure
por: Gašparović, V, et al.
Publicado: (2003)

Use of Oral N-Acetylcysteine (NAC) in Non-Acetaminophen-Induced Acute Hepatic Failure
por: Sharieff, Saleem, et al.
Publicado: (2023)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF
por: McEwan, Phil, et al.
Publicado: (2021)

Cost optimization of the AHF booster energy
por: Craddock, M K, et al.
Publicado: (1988)

Rationale and design of the AUGUST‐AHF Study
por: Zhang, Jingjing, et al.
Publicado: (2020)

Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma
por: Kaplan, Gilaad G, et al.
Publicado: (2005)

Lymphopenia, hypoprolactinemia and lymphocyte depletion in pediatric multiple organ failure
por: Felmet, K, et al.
Publicado: (2003)

Sudden cardiac failure following treatment of metabolic alkalosis with hydrochloric acid
por: Gleiβ, J, et al.
Publicado: (1999)

Association between interleukin-10 (IL-10) gene promoter polymorphisms and outcome in acetaminophen induced acute liver failure requiring admission to a liver intensive care unit
por: Jackson, N, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_bg3rrfjmjc6tjk89sashsgmodc